SCYNEXIS, Inc. ( SCYX) - Key Metrics
SCYX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | $0.03 | -$0.14 | -$0.15 | -$0.15 |
| 2025Q1 | $0.01 | -$0.11 | -$0.15 | -$0.15 |
SCYX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | -1.22 |
| 2025Q1 | ? | -2.18 |
SCYX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -17.34% | ? |
| 2025Q4 | 66.83% | ? |
| 2025Q3 | -22.71% | ? |
| 2025Q2 | -22.33% | ? |
| 2025Q1 | -15.86% | ? |
SCYX
Price: $4.68
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.48 USD
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 45800
Ebitda: -8.0 millionMarket Capitalization: 55.4 million